Altimmune, Inc

(NASDAQ:ALT)

Latest On Altimmune, Inc (ALT):

Date/Time Type Description Signal Details
2023-05-11 16:23 ESTNewsAltimmune GAAP EPS of -$0.40 beats by $0.08N/A
2023-05-11 16:22 ESTNewsAltimmune, Inc. (ALT) Q1 2023 Earnings Call TranscriptN/A
2023-05-10 12:33 ESTNewsAltimmune: A Story, It Seems, Of Too Little Too LateN/A
2023-03-22 23:18 ESTNewsAltimmune hits 10-month low as Goldman Sachs downgrades on weight loss dataN/A
2023-03-21 16:21 ESTNewsAltimmune stock slumps ~35% amid phase 2 trial data of obesity drug pemvidutideN/A
2023-03-21 16:20 ESTNewsAltimmune leads obesity drug developers lower after data for lead assetN/A
2023-02-28 16:09 ESTNewsAltimmune GAAP EPS of -$0.43 beats by $0.11N/A
2023-02-28 16:07 ESTNewsAltimmune (ALT) Q4 2022 Earnings Call TranscriptN/A
2023-02-28 01:16 ESTNewsAltimmune Q4 2022 Earnings PreviewN/A
2023-02-23 11:31 ESTNewsAltimmune's Peptide-Based Therapies Offer Substantial OpportunityN/A
2023-02-21 21:15 ESTNewsAltimmune: Potential Dual Action For Pemvidutide In Obesity, NASHN/A
2022-12-21 01:07 ESTNewsAltimmune rises 5% on positive data from phase 1 trial of Non-Alcoholic Fatty Liver Disease treatmentN/A
2022-12-02 18:36 ESTNewsAltimmune Appears To Have A Winner, But Will The Market Believe?N/A
2022-12-02 01:08 ESTNewsAltimmune spikes as Goldman Sachs sees over 100% upsideN/A
2022-11-30 13:10 ESTNewsAltimmune: Weight Loss Data Signals A Costly ConfusionN/A
2022-11-11 05:50 ESTNewsAltimmune, Inc. (ALT) Q3 2022 Earnings Call TranscriptN/A
2022-11-10 12:39 ESTNewsAltimmune GAAP EPS of -$0.48 beats by $0.01N/A
2022-11-10 12:38 ESTNewsAltimmune rises 5.2% on smaller-than-expected Q3 lossN/A
2022-09-16 22:56 ESTNewsAltimmune defended at H.C. Wainwright ahead of key readout for obesity drugN/A
2022-09-15 11:25 ESTNewsAltimmune: Overreaction On NASH Data Creates Buying OpportunityN/A
2022-09-14 18:07 ESTNewsAltimmune stock slumps 56% despite drug meeting main goal of reducing liver fat in trialN/A
2022-09-14 18:07 ESTNewsPiper Sandler sees Altimmune liver/obesity drug competitive despite weight loss dataN/A
2022-09-07 13:52 ESTNewsReassessing AltimmuneN/A
2022-09-01 01:36 ESTNewsAltimmune sets new 52-week high on rising volumeN/A
2022-08-11 22:36 ESTNewsAltimmune GAAP EPS of -$0.42 beats by $0.05, revenue of $8KN/A
2022-08-11 22:36 ESTNewsAltimmune quarterly net loss narrows as it beats on the bottom lineN/A
2022-08-11 22:36 ESTNewsAltimmune, Inc. (ALT) CEO Vipin Garg on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-11 05:48 ESTNewsAltimmune Q2 2022 Earnings PreviewN/A
2022-06-29 11:28 ESTNewsAltimmune: Several Catalysts In 2 Large Market Indications This YearN/A
2022-05-13 06:49 ESTNewsAltimmune, Inc. (ALT) CEO Vipin K. Garg on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-12 12:17 ESTNewsAltimmune GAAP EPS of -$0.44 beats by $0.14, revenue of $0.03M misses by $0.85MN/A
2022-05-11 18:31 ESTNewsAltimmune Q1 2022 Earnings PreviewN/A
2022-04-07 19:53 ESTNewsAltimmune's New Avatar As A Liver Disease PlayerN/A
2022-04-01 18:50 ESTNewsAltimmune begins enrollment in phase 2 trial of pemvidutide to treat obesityN/A
2022-03-15 16:28 ESTNewsAltimmune GAAP EPS of -$0.57 beats by $0.08, revenue of $3.28M beats by $3.19MN/A
2022-03-15 16:28 ESTNewsAltimmune stock falls ~5% despite Q4 beatN/A
2022-03-15 16:28 ESTNewsAltimmune, Inc. (ALT) CEO Vipin Garg on Q4 2021 Results - Earnings Call TranscriptN/A
2022-01-31 13:06 ESTNewsFDA clears Altimmune's pemvidutide application for obesityN/A
2022-01-03 16:07 ESTNewsAltimmune: Changing Focus To Pemvidutide In 2022N/A
2021-12-13 14:56 ESTNewsNew finance chief at AltimmuneN/A
2021-11-23 16:46 ESTNewsWarning: ALT is at high risk of performing badlyN/A
2021-11-22 18:32 ESTNewsAltimmune (ALT) Presents At 2021 Virtual Healthcare Conference - SlideshowN/A
2021-11-11 20:59 ESTNewsAltimmune, Inc.'s (ALT) CEO Vipin Garg on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-11 00:44 ESTNewsAltimmune EPS misses by $0.38, beats on revenueN/A
2021-11-11 00:43 ESTNewsAltimmune, Inc. (ALT) CEO Vipin Garg on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-10 02:01 ESTNewsAltimmune Q3 2021 Earnings PreviewN/A
2021-10-16 20:22 ESTNewsAltimmune: Changing The ThesisN/A
2021-10-04 22:54 ESTNewsAltimmune initiates Phase 1b trial of pemvidutide in non-alcoholic fatty liver diseaseN/A
2021-09-28 11:25 ESTNewsAltimmune spikes on data readout for obesity therapy tomorrowN/A
2021-09-28 11:25 ESTNewsAltimmune slips after posting 12-week data from Phase 1 trial for weight loss therapyN/A

About Altimmune, Inc (ALT):

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing intranasal vaccines, immune modulating therapies, and treatments for liver disease. The company develops AdCOVID, a single-dose intranasal vaccine that is in Phase I clinical trial to protect against COVID-19; T-COVID, an intranasal immune modulating therapeutic candidate, which is in Phase I/II clinical trial to evaluate the potential of T-COVID to prevent clinical worsening in patients with early COVID-19; NasoShield, an anthrax vaccine product candidate that is in a Phase 1b trial; and NasoVAX, a recombinant intranasal vaccine product candidate, which completed Phase IIa clinical trial for the treatment of seasonal and pandemic use. It also focuses on developing ALT-801, a novel peptide-based dual GLP-1/glucagon receptor agonist for the treatment of non-alcoholic steatohepatitis that is in Phase I clinical trial; and HepTcell, an immunotherapeutic product candidate, which is in Phase II clinical trial for patients chronically infected with the hepatitis B virus. Altimmune, Inc. has a collaboration with the University of Alabama at Birmingham for the development of AdCOVID. The company is headquartered in Gaithersburg, Maryland.

ALT Quotes by TradingView

See Advanced Chart

General

  • Name Altimmune, Inc
  • Symbol ALT
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 43
  • Last Split Factor1:30
  • Last Split Date2018-09-14
  • Fiscal Year EndDecember
  • IPO Date2005-10-06
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://altimmune.com
View More

Valuation

  • Trailing PE 1.82
  • Price/Sales (Trailing 12 Mt.) 54.44
  • Price/Book (Most Recent Quarter) 2.86
  • Enterprise Value Revenue 52.73
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.04
  • Next Year EPS Estimate $0.70
  • Next Quarter EPS Estimate -$0.18
  • Operating Margin -471%
  • Return on Assets -16%
  • Return on Equity -36%
  • Revenue 8.19 million
  • Earnings Per Share -$4.16
  • Revenue Per Share $0.32
  • Gross Profit -25324291
  • Quarterly Earnings Growth 301.7%
View More

Highlights

  • Market Capitalization 641.59 million
  • EBITDA -11790191
  • Analyst Target Price $41.83
  • Book Value Per Share $6.11
View More

Share Statistics

  • Shares Outstanding 37.15 million
  • Shares Float 29.2 million
  • % Held by Insiders 651%
  • % Held by Institutions 67.3%
  • Shares Short 2.41 million
  • Shares Short Prior Month 2.52 million
  • Short Ratio 1.22
  • Short % of Float 8%
  • Short % of Shares Outstanding 7%
View More

Technicals

  • Beta 1.37
  • 52 Week High $35.1
  • 52 Week Low $2.68
  • 50 Day Moving Average 17.82
  • 200 Day Moving Average 13.78
View More

Dividends

  • Dividend Date 2018-09-14
  • ExDividend Date 2017-01-20
  • Dividend Yield 0%
View More

Altimmune, Inc (ALT) Dividend Calendar:

ALT's last dividend payment was made to shareholders on September 14, 2018.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Altimmune, Inc (ALT) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$2.31 million-$0.17-$0.8078.84%
2020-09-302020-11-09$2.94 million-$0.54-$0.7628.95%
2020-06-302020-08-11$N/A-$0.94-$0.29-229.82%
2020-03-312020-05-13$2.21 million-$0.26-$0.3218.75%
2019-12-312020-03-27$N/A-$0.25-$0.263.85%
2019-09-302019-11-13$643978-$0.74-$0.19-289.47%
2019-06-302019-08-13$1.63 million-$0.26-$0.25-4%
2019-03-312019-04-01$2.96 million-$0.27-$2.8090.36%
2018-12-312019-03-31$2.59 million-$2.34-$2.8016.43%
2018-09-302018-11-13$2.63 million-$1.73-$3.6051.94%
2018-06-302018-08-14$2.42 million-$10.20-$4.50-126.67%
2018-03-312018-05-15$2.69 million-$8.73-$15.0041.78%
2017-12-312018-03-28$2.3 million-$2.40-$15.0084%
2017-09-302017-11-09$4.59 million-$10.20-$8.40-21.43%
2017-06-302017-08-10$3.04 million-$7.73
2014-09-302014-11-06$962451-$24.00-$7.50-220%
2014-06-302014-08-04$3.66 million-$3.00-$16.5081.82%
2014-03-312014-05-08$3.74 million-$12.00-$18.0033.33%
2013-12-312014-03-11$3.65 million-$24.00-$15.00-60%
2013-09-302013-11-07$3.49 million-$24.00-$10.50-128.57%
2013-06-302013-08-07$4.3 million-$6.00-$9.0033.33%
2013-03-312013-05-08$6.48 million-$12.00-$15.0020%
2012-12-312013-03-13$6.01 million-$6.00-$12.0050%
2012-09-302012-11-06$6.7 million-$1.33-$9.0085.25%
2012-06-302012-08-07$6.32 million-$6.00-$9.0033.33%
2012-03-312012-05-08$6.15 million-$18.00-$15.00-20%
2011-12-312012-03-08$3.00-$32.00109.38%
2011-09-302011-11-09$5.26 million-$0.21-$25.0099.17%
2011-06-302011-08-10$6.43 million-$15.00-$31.5052.38%
2011-03-312011-05-11-$12.00-$29.0058.62%
2010-12-312011-03-28-$138.00-$26.00-430.77%
2010-09-302010-11-11-$42.00-$52.0019.23%
2010-06-302010-08-12-$66.00-$61.50-7.32%
2010-03-312010-05-11-$84.00-$51.00-64.71%
2009-12-312010-03-23-$60.00-$61.502.44%
2009-09-302009-11-12-$150.00-$57.00-163.16%
2009-06-302009-08-13-$72.00-$54.00-33.33%
2009-03-312009-05-15-$69.00-$60.00-15%
2008-12-312009-03-30-$51.00-$78.0034.62%
2008-09-302008-11-13-$60.00-$78.0023.08%
2008-06-302008-08-13-$296.82
2008-03-312008-05-14-$68.15
2007-09-302007-11-13-$20.56
2007-03-312007-03-31$7.48
2006-12-312006-12-31-$11,895.61
2006-09-302006-09-30$6.64
2006-06-302006-06-30$6.11
2006-03-312006-03-31$4.47
2005-12-312005-12-31$4.81

Altimmune, Inc (ALT) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Altimmune, Inc (ALT) Chart:

ALT chart by TradingView

Altimmune, Inc (ALT) News:

Below you will find a list of latest news for Altimmune, Inc (ALT) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Altimmune, Inc (ALT) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-06-260.52.15CALL6 17940TRUE0.050.02
2026-06-2611.65CALL6 1100TRUE-0.34-0.17
2026-06-261.50CALL0 971442.25TRUE00
2026-06-2620.85CALL0 42392.11TRUE00
2026-06-262.50.32CALL2 48168.91TRUE0.070.28
2026-06-2630.04CALL55 34585.27FALSE-0.01-0.2
2026-06-263.50.04CALL10 428143.84FALSE0.040
2026-06-2640CALL0 68318.48FALSE00
2026-06-264.50CALL0 0991.58FALSE00
2026-06-2650CALL0 201820.05FALSE00
2026-06-265.50CALL0 01005.69FALSE00
2026-06-2660CALL0 0746.61FALSE00
2026-06-266.50.01CALL2 01020.24FALSE0.010
2026-06-260.50PUT0 0697.99FALSE00
2026-06-2610.03PUT1 0416.7FALSE0.030
2026-06-261.50.03PUT4 4575.91FALSE0.030
2026-06-2620.05PUT2 6258.12FALSE-0.01-0.17
2026-06-262.50PUT0 81131.72FALSE00
2026-06-2630.33PUT2 470TRUE-0.12-0.27
2026-06-263.50.77PUT5 20TRUE0.770
2026-06-2641.28PUT7 20TRUE-0.19-0.13
2026-06-264.51.82PUT1 00TRUE1.820
2026-06-2652.2PUT2 10TRUE0.010
2026-06-265.52.8PUT1 40TRUE-0.02-0.01
2026-06-2663.2PUT2 00TRUE3.20
2026-06-266.50PUT0 0280.34TRUE00
2026-07-020.52.08CALL0 619838.67TRUE00
2026-07-0210CALL0 900TRUE00
2026-07-021.50CALL0 661138.64TRUE00
2026-07-0220CALL0 22335.46TRUE00
2026-07-022.50CALL0 3168.84TRUE00
2026-07-0230.05CALL97 24390.62FALSE-0.05-0.5
2026-07-023.50CALL0 1721139.52FALSE00
2026-07-0240CALL0 44250.2FALSE00
2026-07-024.50CALL0 2413.21FALSE00
2026-07-0250CALL0 0432.74FALSE00
2026-07-025.50CALL0 0829.89FALSE00
2026-07-0260.02CALL2 0276.43FALSE0.020
2026-07-020.50PUT0 0522.15FALSE00
2026-07-0210PUT0 2308.92FALSE00
2026-07-021.50.1PUT2 41252.18FALSE0.10
2026-07-0220.1PUT4 4126.52FALSE0.10
2026-07-022.50PUT0 0188.24FALSE00
2026-07-0230PUT0 8784.39TRUE00
2026-07-023.50.8PUT4 40TRUE-0.09-0.1
2026-07-0240PUT0 0245.48TRUE00
2026-07-024.50PUT0 3159.77TRUE00
2026-07-0252.32PUT1 00TRUE2.320
2026-07-025.50PUT0 0297.31TRUE00
2026-07-0263.32PUT1 00TRUE3.320
2026-07-100.52.36CALL169 700998.11TRUE0.120.05
2026-07-1011.73CALL8 49479.63TRUE1.730
2026-07-101.50CALL0 13433.7TRUE00
2026-07-1020CALL0 0167.81TRUE00
2026-07-102.50CALL0 0148.79TRUE00
2026-07-1030.07CALL634 61305.99FALSE-0.03-0.3
2026-07-103.50CALL0 101119.28FALSE00
2026-07-1040CALL0 0166.62FALSE00
2026-07-104.50CALL0 0331.27FALSE00
2026-07-1050CALL0 0367.93FALSE00
2026-07-105.50CALL0 0681.71FALSE00
2026-07-1060CALL0 0399.01FALSE00
2026-07-100.50PUT0 19410.66FALSE00
2026-07-1010PUT0 17239.91FALSE00
2026-07-101.50PUT0 7259.26FALSE00
2026-07-1020.05PUT4 672.33FALSE0.050
2026-07-102.50PUT0 0144.66FALSE00
2026-07-1030PUT0 190TRUE00
2026-07-103.50PUT0 30TRUE00
2026-07-1041.31PUT1 20TRUE-0.08-0.06
2026-07-104.51.83PUT1 00TRUE1.830
2026-07-1050PUT0 00TRUE00
2026-07-105.50PUT0 0451.21TRUE00
2026-07-1060PUT0 00TRUE00
2026-07-170.53.38CALL10 60621.77TRUE1.230.57
2026-07-1710CALL0 270TRUE00
2026-07-171.50CALL0 00TRUE00
2026-07-1720CALL0 200TRUE00
2026-07-172.50.35CALL0 2087.82TRUE00
2026-07-1730.12CALL179 939109.98FALSE0.020.2
2026-07-173.50.04CALL10 769991.74FALSE00
2026-07-1740CALL0 639115.21FALSE00
2026-07-174.50CALL0 81307.03FALSE00
2026-07-1750CALL0 0279.63FALSE00
2026-07-175.50CALL0 0349.03FALSE00
2026-07-1760CALL0 20223.49FALSE00
2026-07-170.50PUT0 0353.17FALSE00
2026-07-1710PUT0 1203.94FALSE00
2026-07-171.50PUT0 2218.85FALSE00
2026-07-1720.05PUT0 4123.09FALSE00
2026-07-172.50.1PUT1 00FALSE0.10
2026-07-1730.4PUT2 4500TRUE-0.05-0.11
2026-07-173.50.9PUT0 40TRUE00
2026-07-1741.18PUT0 10TRUE00
2026-07-174.50PUT0 00TRUE00
2026-07-1750PUT0 00TRUE00
2026-07-175.52.7PUT0 00TRUE00
2026-07-1760PUT0 00TRUE00
2026-07-240.52.23CALL517 586606.04TRUE-0.03-0.01
2026-07-2411.81CALL5 76447.29TRUE0.140.08
2026-07-241.51.13CALL0 400TRUE00
2026-07-2420.68CALL0 30475.49TRUE00
2026-07-242.50CALL0 0458.58TRUE00
2026-07-2430CALL0 4114.16FALSE00
2026-07-243.50CALL0 0297.3FALSE00
2026-07-2440CALL0 0165.65FALSE00
2026-07-244.50CALL0 0384.54FALSE00
2026-07-2450CALL0 0541.85FALSE00
2026-07-245.50CALL0 0559.29FALSE00
2026-07-240.50PUT0 3312.93FALSE00
2026-07-2410.05PUT2 10372.58FALSE00
2026-07-241.50.05PUT6 11124.61FALSE00
2026-07-2420.09PUT0 770.07FALSE00
2026-07-242.50PUT0 2841.69FALSE00
2026-07-2430PUT0 066.43TRUE00
2026-07-243.50.95PUT0 10TRUE00
2026-07-2440PUT0 0133.77TRUE00
2026-07-244.50PUT0 0134.35TRUE00
2026-07-2450PUT0 0170.96TRUE00
2026-07-245.50PUT0 0323.36TRUE00
2026-07-310.52.22CALL166 477558.14TRUE-0.01-0
2026-07-3111.86CALL1 12451.52TRUE0.210.13
2026-07-311.51.2CALL4 4287.05TRUE00
2026-07-3120CALL0 0199.21TRUE00
2026-07-312.50CALL0 0111.46TRUE00
2026-07-3130.2CALL6 28143.47FALSE00
2026-07-313.50CALL0 0218.22FALSE00
2026-07-3140CALL0 0156.98FALSE00
2026-07-314.50CALL0 0360.98FALSE00
2026-07-3150CALL0 0507.68FALSE00
2026-07-310.50.07PUT2 3282.58FALSE0.020.4
2026-07-3110.05PUT2 6159.13FALSE00
2026-07-311.50.05PUT0 14181.03FALSE00
2026-07-3120.1PUT0 5243.95FALSE00
2026-07-312.50PUT0 2647.44FALSE00
2026-07-3130PUT0 00TRUE00
2026-07-313.50PUT0 00TRUE00
2026-07-3140PUT0 00TRUE00
2026-07-314.50PUT0 00TRUE00
2026-07-3150PUT0 0308.15TRUE00
2026-08-210.50CALL0 0676.92TRUE00
2026-08-2110CALL0 00TRUE00
2026-08-211.50CALL0 0463.59TRUE00
2026-08-2120CALL0 0525.43TRUE00
2026-08-212.50CALL0 0404.47TRUE00
2026-08-2130.35CALL1 0167.18FALSE0.350
2026-08-213.50.15CALL371 0112.71FALSE0.150
2026-08-2140CALL0 0419.8FALSE00
2026-08-214.50CALL0 0437.27FALSE00
2026-08-2150CALL0 0444.82FALSE00
2026-08-210.50.1PUT4 0222.27FALSE0.10
2026-08-2110.15PUT2 0216.21FALSE0.150
2026-08-211.50.09PUT12 0100.48FALSE0.090
2026-08-2120.15PUT2 0356.19FALSE0.150
2026-08-212.50.25PUT8 00FALSE0.250
2026-08-2130PUT0 00TRUE00
2026-08-213.50PUT0 00TRUE00
2026-08-2140PUT0 00TRUE00
2026-08-214.50PUT0 00TRUE00
2026-08-2150PUT0 00TRUE00
2026-09-180.52.23CALL0 41610TRUE00
2026-09-1811.8CALL1 47520.19TRUE1.80
2026-09-181.50CALL0 0395.84TRUE00
2026-09-1820CALL0 514210.48TRUE00
2026-09-182.50.7CALL31 108169.39TRUE0.150.27
2026-09-1830.35CALL0 2465205.46FALSE00
2026-09-183.50.23CALL200 3285143.1FALSE-0.02-0.08
2026-09-1840.16CALL4 2492154.1FALSE0.010.07
2026-09-184.50.14CALL85 42144.92FALSE0.140
2026-09-1850.1CALL372 3918136.83FALSE0.030.43
2026-09-185.50CALL0 44238.63FALSE00
2026-09-1860.07CALL20 1222141.44FALSE-0.01-0.13
2026-09-1870CALL0 595264.43FALSE00
2026-09-1880.09CALL1 323165.86FALSE0.090
2026-09-1890CALL0 27289.25FALSE00
2026-09-18100.05CALL0 242239.63FALSE00
2026-09-180.50PUT0 2210.57FALSE00
2026-09-1810.1PUT1 13107.44FALSE0.10
2026-09-181.50PUT0 4159.4FALSE00
2026-09-1820PUT0 300FALSE00
2026-09-182.50PUT0 20FALSE00
2026-09-1830.6PUT60 3690TRUE0.60
2026-09-183.50PUT0 00TRUE00
2026-09-1840PUT0 3020TRUE00
2026-09-184.50PUT0 00TRUE00
2026-09-1850PUT0 1300TRUE00
2026-09-185.50PUT0 00TRUE00
2026-09-1860PUT0 120TRUE00
2026-09-1870PUT0 10TRUE00
2026-09-1880PUT0 00TRUE00
2026-09-1890PUT0 00TRUE00
2026-09-18100PUT0 00TRUE00
2026-12-180.50CALL0 0679.45TRUE00
2026-12-1810CALL0 4331.83TRUE00
2026-12-181.50CALL0 0247.37TRUE00
2026-12-1820CALL0 17195.15TRUE00
2026-12-182.50CALL0 15203.39TRUE00
2026-12-1830.6CALL1 154202.88FALSE0.60
2026-12-183.50CALL0 57180.39FALSE00
2026-12-1840.43CALL0 260189.51FALSE00
2026-12-184.50.42CALL0 20168.6FALSE00
2026-12-1850CALL0 807153.39FALSE00
2026-12-185.50CALL0 18202.85FALSE00
2026-12-1860CALL0 27180.81FALSE00
2026-12-180.50PUT0 1634.94FALSE00
2026-12-1810PUT0 0161.12FALSE00
2026-12-181.50PUT0 074.14FALSE00
2026-12-1820PUT0 840FALSE00
2026-12-182.50PUT0 30FALSE00
2026-12-1830PUT0 3450TRUE00
2026-12-183.50PUT0 00TRUE00
2026-12-1840PUT0 440TRUE00
2026-12-184.50PUT0 00TRUE00
2026-12-1850PUT0 00TRUE00
2026-12-185.50PUT0 00TRUE00
2026-12-1860PUT0 60TRUE00
2027-01-150.50CALL0 0936.32TRUE00
2027-01-1510CALL0 234643.2TRUE00
2027-01-151.50CALL0 0283.17TRUE00
2027-01-1521.1CALL36 6316241.19TRUE0.050.05
2027-01-152.50.82CALL10 63218.49TRUE0.070.09
2027-01-1530.6CALL1 4238194.7FALSE-0.05-0.08
2027-01-153.50.47CALL656 92203.69FALSE-0.03-0.06
2027-01-1540.4CALL556 4336171.16FALSE-0.1-0.2
2027-01-154.50.32CALL6 42182.27FALSE0.320
2027-01-1550.3CALL701 9850180.57FALSE-0.01-0.03
2027-01-155.50.27CALL17 128188.19FALSE-0.03-0.1
2027-01-1560.27CALL17 167183.37FALSE0.270
2027-01-1570.17CALL26 5603182.03FALSE-0.01-0.06
2027-01-15100.15CALL7 9344190.56FALSE0.150
2027-01-15120.15CALL8 1381193FALSE0.070.88
2027-01-15150.28CALL1 1878213.24FALSE0.280
2027-01-15170.07CALL0 2871219.87FALSE00
2027-01-15200.07CALL6 16354199.5FALSE00
2027-01-150.50PUT0 2364.79FALSE00
2027-01-1510PUT0 700FALSE00
2027-01-151.50PUT0 10FALSE00
2027-01-1520.29PUT0 3760FALSE00
2027-01-152.50.56PUT0 2660FALSE00
2027-01-1530PUT0 7360TRUE00
2027-01-153.50PUT0 00TRUE00
2027-01-1540PUT0 13610TRUE00
2027-01-154.50PUT0 00TRUE00
2027-01-1550PUT0 12290TRUE00
2027-01-155.50PUT0 00TRUE00
2027-01-1560PUT0 00TRUE00
2027-01-1570PUT0 5590TRUE00
2027-01-15100PUT0 4530TRUE00
2027-01-15120PUT0 210TRUE00
2027-01-15150PUT0 10TRUE00
2027-01-15170PUT0 00TRUE00
2027-01-15200PUT0 00TRUE00
2028-01-210.50CALL0 20TRUE00
2028-01-2110CALL0 930TRUE00
2028-01-211.50CALL0 21495.06TRUE00
2028-01-2122.84CALL0 138707.66TRUE00
2028-01-212.52.52CALL0 23670.96TRUE00
2028-01-2131.19CALL1 4715355.3FALSE1.190
2028-01-213.51.16CALL2 1330.84FALSE1.160
2028-01-2141.05CALL90 777259.8FALSE1.050
2028-01-214.50CALL0 180FALSE00
2028-01-2150.75CALL17 870292.32FALSE0.750
2028-01-215.50.85CALL13 36293.01FALSE-0.99-0.54
2028-01-2170.66CALL90 2126293.08FALSE-0.3-0.31
2028-01-21100CALL0 7480253.82FALSE00
2028-01-210.50PUT0 30FALSE00
2028-01-2110PUT0 50FALSE00
2028-01-211.50PUT0 20FALSE00
2028-01-2120PUT0 10FALSE00
2028-01-212.50PUT0 00FALSE00
2028-01-2130PUT0 250TRUE00
2028-01-213.50PUT0 00TRUE00
2028-01-2140PUT0 190TRUE00
2028-01-214.50PUT0 00TRUE00
2028-01-2150PUT0 430TRUE00
2028-01-215.50PUT0 00TRUE00
2028-01-2170PUT0 390TRUE00
2028-01-21107.5PUT0 1030TRUE00

Latest ALT Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST1$9.25
Jun 13, 2022 7:59 PM EST399$9.25
Jun 13, 2022 7:59 PM EST58$9.25
Jun 13, 2022 7:59 PM EST100$9.25
Jun 13, 2022 7:59 PM EST200$9.235

Altimmune, Inc (ALT) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320018161/0000899243-20-018161-index.htm
2019-04-15UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1326190/000000000019007165/0000000000-19-007165-index.htm
2019-08-16UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1326190/000000000019012559/0000000000-19-012559-index.htm
2019-08-22UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1326190/000000000019012749/0000000000-19-012749-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924319016650/0000899243-19-016650-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924319017407/0000899243-19-017407-index.htm
2019-09-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924319022846/0000899243-19-022846-index.htm
2019-09-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924319023316/0000899243-19-023316-index.htm
2019-09-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924319023318/0000899243-19-023318-index.htm
2019-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924319028409/0000899243-19-028409-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320000074/0000899243-20-000074-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320000275/0000899243-20-000275-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320000276/0000899243-20-000276-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320000279/0000899243-20-000279-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320000286/0000899243-20-000286-index.htm
2020-02-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320002630/0000899243-20-002630-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320002960/0000899243-20-002960-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320002986/0000899243-20-002986-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320003006/0000899243-20-003006-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320006772/0000899243-20-006772-index.htm
2020-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320009897/0000899243-20-009897-index.htm
2020-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320011911/0000899243-20-011911-index.htm
2020-05-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320012836/0000899243-20-012836-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320012840/0000899243-20-012840-index.htm
2020-05-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320013395/0000899243-20-013395-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320014937/0000899243-20-014937-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320017823/0000899243-20-017823-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320017824/0000899243-20-017824-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320017826/0000899243-20-017826-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320017831/0000899243-20-017831-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320017833/0000899243-20-017833-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320017835/0000899243-20-017835-index.htm
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320018161/0000899243-20-018161-index.htm
2020-08-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320021020/0000899243-20-021020-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320021205/0000899243-20-021205-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320021207/0000899243-20-021207-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320021212/0000899243-20-021212-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320021219/0000899243-20-021219-index.htm
2020-08-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320023683/0000899243-20-023683-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026409/0000899243-20-026409-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026410/0000899243-20-026410-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026411/0000899243-20-026411-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026412/0000899243-20-026412-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026413/0000899243-20-026413-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026414/0000899243-20-026414-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026415/0000899243-20-026415-index.htm
2020-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026921/0000899243-20-026921-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320028535/0000899243-20-028535-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320028536/0000899243-20-028536-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320028537/0000899243-20-028537-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320028538/0000899243-20-028538-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320028539/0000899243-20-028539-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320028540/0000899243-20-028540-index.htm
2020-11-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320030113/0000899243-20-030113-index.htm
2019-03-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000092542119000135/0000925421-19-000135-index.htm
2019-03-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000092542119000137/0000925421-19-000137-index.htm
2018-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297518001065/0001012975-18-001065-index.htm
2018-10-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297518001091/0001012975-18-001091-index.htm
2018-10-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297518001100/0001012975-18-001100-index.htm
2018-12-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297518001271/0001012975-18-001271-index.htm
2018-12-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297518001273/0001012975-18-001273-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000028/0001012975-19-000028-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000029/0001012975-19-000029-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000031/0001012975-19-000031-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000033/0001012975-19-000033-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000035/0001012975-19-000035-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000037/0001012975-19-000037-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000039/0001012975-19-000039-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000041/0001012975-19-000041-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000043/0001012975-19-000043-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000106823820000055/0001068238-20-000055-index.htm
2018-10-05SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000110465918060692/0001104659-18-060692-index.htm
2019-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000110465919005825/0001104659-19-005825-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000110465919008563/0001104659-19-008563-index.htm
2020-06-01SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000110465920068336/0001104659-20-068336-index.htm
2020-06-25SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1326190/000110465920076855/0001104659-20-076855-index.htm
2020-09-24SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000110465920108310/0001104659-20-108310-index.htm
2020-10-05SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000110465920112175/0001104659-20-112175-index.htm
2018-09-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518280602/0001193125-18-280602-index.htm
2018-09-24424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326190/000119312518280966/0001193125-18-280966-index.htm
2018-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518281668/0001193125-18-281668-index.htm
2018-09-26S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1326190/000119312518284095/0001193125-18-284095-index.htm
2018-09-27CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1326190/000119312518285764/0001193125-18-285764-index.htm
2018-09-27CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1326190/000119312518285783/0001193125-18-285783-index.htm
2018-09-28POS EXPost-effective amendment adding exhibits to registration statement [Rule 462(d)]https://www.sec.gov/Archives/edgar/data/1326190/000119312518286447/0001193125-18-286447-index.htm
2018-10-01424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1326190/000119312518289729/0001193125-18-289729-index.htm
2018-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518289763/0001193125-18-289763-index.htm
2018-10-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000119312518293265/0001193125-18-293265-index.htm
2018-10-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518295412/0001193125-18-295412-index.htm
2018-10-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326190/000119312518295424/0001193125-18-295424-index.htm
2018-10-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326190/000119312518296082/0001193125-18-296082-index.htm
2018-10-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518304261/0001193125-18-304261-index.htm
2018-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518325584/0001193125-18-325584-index.htm
2018-11-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1326190/000119312518325587/0001193125-18-325587-index.htm
2018-11-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518335258/0001193125-18-335258-index.htm
2018-11-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518339667/0001193125-18-339667-index.htm
2018-11-30S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1326190/000119312518339756/0001193125-18-339756-index.htm
2018-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518340078/0001193125-18-340078-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000119312519033928/0001193125-19-033928-index.htm
2019-03-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519067835/0001193125-19-067835-index.htm
2019-03-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519070141/0001193125-19-070141-index.htm
2019-03-11424B2Prospectus [Rule 424(b)(2)]https://www.sec.gov/Archives/edgar/data/1326190/000119312519070146/0001193125-19-070146-index.htm
2019-03-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519076851/0001193125-19-076851-index.htm
2019-04-04S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1326190/000119312519097986/0001193125-19-097986-index.htm
2019-04-04S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1326190/000119312519097996/0001193125-19-097996-index.htm
2019-04-11CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1326190/000119312519103831/0001193125-19-103831-index.htm
2019-04-11CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1326190/000119312519104131/0001193125-19-104131-index.htm
2019-06-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519168149/0001193125-19-168149-index.htm
2019-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519171212/0001193125-19-171212-index.htm
2019-06-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519178904/0001193125-19-178904-index.htm
2019-07-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519190926/0001193125-19-190926-index.htm
2019-07-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519193586/0001193125-19-193586-index.htm
2019-08-09PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1326190/000119312519218069/0001193125-19-218069-index.htm
2019-08-14S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1326190/000119312519221188/0001193125-19-221188-index.htm
2019-08-19CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1326190/000119312519224352/0001193125-19-224352-index.htm
2019-08-19PRER14APreliminary Proxy Soliciting materialshttps://www.sec.gov/Archives/edgar/data/1326190/000119312519224357/0001193125-19-224357-index.htm
2019-08-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519225595/0001193125-19-225595-index.htm
2019-08-22DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1326190/000119312519226618/0001193125-19-226618-index.htm
2019-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519259847/0001193125-19-259847-index.htm
2020-03-27424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326190/000119312520087649/0001193125-20-087649-index.htm
2020-03-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520088680/0001193125-20-088680-index.htm
2020-04-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520100902/0001193125-20-100902-index.htm
2020-05-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520139801/0001193125-20-139801-index.htm
2020-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520156447/0001193125-20-156447-index.htm
2020-06-01424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326190/000119312520156472/0001193125-20-156472-index.htm
2020-07-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520191485/0001193125-20-191485-index.htm
2020-07-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326190/000119312520191866/0001193125-20-191866-index.htm
2020-07-15424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326190/000119312520192791/0001193125-20-192791-index.htm
2020-07-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520194024/0001193125-20-194024-index.htm
2020-07-168-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520194052/0001193125-20-194052-index.htm
2020-08-21DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1326190/000119312520226963/0001193125-20-226963-index.htm
2020-08-21S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1326190/000119312520226971/0001193125-20-226971-index.htm
2020-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520254566/0001193125-20-254566-index.htm
2020-02-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000120919120009672/0001209191-20-009672-index.htm
2018-10-17SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000121390018014006/0001213900-18-014006-index.htm
2019-02-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000121390019001904/0001213900-19-001904-index.htm
2020-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000121390020003212/0001213900-20-003212-index.htm
2019-02-01SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000139382519000035/0001393825-19-000035-index.htm
2020-01-31SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000139382520000012/0001393825-20-000012-index.htm
2019-04-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1326190/000156459019010429/0001564590-19-010429-index.htm
2019-04-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000156459019010435/0001564590-19-010435-index.htm
2019-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1326190/000156459019019139/0001564590-19-019139-index.htm
2019-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000156459019019146/0001564590-19-019146-index.htm
2019-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1326190/000156459019031795/0001564590-19-031795-index.htm
2019-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000156459019031811/0001564590-19-031811-index.htm
2019-11-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1326190/000156459019043231/0001564590-19-043231-index.htm
2019-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000156459019043240/0001564590-19-043240-index.htm
2020-03-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000156459020013376/0001564590-20-013376-index.htm
2020-03-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1326190/000156459020013377/0001564590-20-013377-index.htm
2020-05-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1326190/000156459020025123/0001564590-20-025123-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000156459020025137/0001564590-20-025137-index.htm
2020-08-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000156459020039298/0001564590-20-039298-index.htm
2020-08-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1326190/000156459020039314/0001564590-20-039314-index.htm
2020-05-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000173804820000001/0001738048-20-000001-index.htm
2020-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000173804820000003/0001738048-20-000003-index.htm
2018-09-27EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1326190/999999999518002478/9999999995-18-002478-index.htm
2019-04-12EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1326190/999999999519000701/9999999995-19-000701-index.htm
2018-10-04CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1326190/999999999718008376/9999999997-18-008376-index.htm

Altimmune, Inc (ALT) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Altimmune, Inc (ALT). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 651%
Institutional Ownership: 6730%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-07-31William Michael BrownChief Financial OfficerBuy7,920.001.4611,563.2015,981.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320021212/0000899243-20-021212-index.htm
2020-05-15VELOCITY PHARMACEUTICAL HOLDINGS LLC10% Share HolderSell30,622.004.65142,392.301,687,250.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320013395/0000899243-20-013395-index.htm
2020-05-14VELOCITY PHARMACEUTICAL HOLDINGS LLC10% Share HolderSell169,378.004.81814,708.181,717,872.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320013395/0000899243-20-013395-index.htm
2018-10-09Wayne PisanoDirectorBuy2,000.004.599,180.002,000.00https://www.sec.gov/Archives/edgar/data/1326190/000101297518001100/0001012975-18-001100-index.htm
2020-05-26Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy309,453.008.792,720,091.872,005,817.00https://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm
2020-05-26Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy390,547.009.783,819,549.662,396,364.00https://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm
2020-05-27Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy125,162.007.23904,921.262,521,526.00https://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm
2020-05-27Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy277,000.007.922,193,840.002,798,526.00https://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm
2020-05-28Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy27,763.007.79216,273.772,826,289.00https://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm
2020-05-28Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy173,711.008.871,540,816.573,000,000.00https://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm
2018-11-30Vipin K GargPresident and CEOBuy322,907.00322,907.00https://www.sec.gov/Archives/edgar/data/1326190/000101297518001273/0001012975-18-001273-index.htm
2020-07-31Vipin K GargChief Financial OfficerBuy11,674.001.4617,044.04325,789.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320021205/0000899243-20-021205-index.htm
2020-01-31Vipin K GargPresident and CEOBuy11,289.001.4616,481.94326,206.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320002986/0000899243-20-002986-index.htm
2019-09-05Vipin K GargPresident and CEOBuy20,000.002.1042,000.00342,907.00https://www.sec.gov/Archives/edgar/data/1326190/000089924319022846/0000899243-19-022846-index.htm
2020-06-15Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy1,500,000.007.5411,310,000.004,500,000.00https://www.sec.gov/Archives/edgar/data/1326190/000173804820000003/0001738048-20-000003-index.htm
2020-01-31M Scot RobertsChief Scientific OfficerBuy3,698.001.465,399.085,535.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320002960/0000899243-20-002960-index.htm
2020-01-31William Michael BrownChief Financial OfficerBuy8,061.001.4611,769.068,061.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320003006/0000899243-20-003006-index.htm
2020-07-31Matthew Scott HarrisChief Medical OfficerBuy8,084.001.4611,802.648,084.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320021219/0000899243-20-021219-index.htm
2020-07-31M Scot RobertsChief Scientific OfficerBuy3,859.001.465,634.149,394.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320021207/0000899243-20-021207-index.htm